The Patent Finder

Terms ending in 2039

Forma Therapeutics, Inc.

Every in-force patent on Forma Therapeutics, Inc.'s record whose computed term ends in 2039, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 10,532,047Solid Forms of ((S)-5-((1-(6-Chloro-2-OXO-1,2-Dihydroquinolin-3-YL)ETHYL)AMINO)-1-Methyl-6-OXO-1,6-Dihydropyridine-2-Carbonitrile
In force
 · High confidence
Forma Therapeutics, Inc.In forceHigh confidence
US 10,959,994Solid Forms of ((S)-5-((1-(6-Chloro-2-OXO-1,2-Dihydroquinolin-3-YL)ETHYL)AMINO)-1-Methyl-6-OXO-1,6-Dihydropyridine-2-Carbonitrile
In force
 · High confidence
Forma Therapeutics, Inc.In forceHigh confidence
US 11,013,733Inhibiting Mutant Isocitrate Dehydrogenase 1 (mIDH-1)
In force
 · High confidence
Forma Therapeutics, Inc.In forceHigh confidence
US 11,013,734Treating Patients Harboring an Isocitrate DEHYDROGENASE-1 (IDH-1) Mutation
In force
 · High confidence
Forma Therapeutics, Inc.In forceHigh confidence
US 11,311,527Inhibiting Mutant Isocitrate Dehydrogenase 1 (mIDH-1)
In force
 · High confidence
Forma Therapeutics, Inc.In forceHigh confidence
US 11,376,246Inhibiting Mutant IDH-1
In force
 · High confidence
Forma Therapeutics, Inc.In forceHigh confidence
US 11,497,743Treating Patients Harboring an Isocitrate Dehydrogenase 1 (IDH-1) Mutation
In force
 · High confidence
Forma Therapeutics, Inc.In forceHigh confidence
US 11,576,906Inhibiting Mutant IDH-1
In force
 · High confidence
Forma Therapeutics, Inc.In forceHigh confidence
US 11,963,956Inhibiting Mutant Isocitrate Dehydrogenase 1 (mIDH-1)
In force
 · High confidence
Forma Therapeutics, Inc.In forceHigh confidence
US 12,053,463Solid Forms of ((S)-5-((1-(6-Chloro-2-OXO-1,2-Dihydroquinolin-3-YL)ETHYL)AMINO)-1-Methyl-6-OXO-1,6-Dihydropyridine-2-Carbonitrile
In force
 · Medium confidence
Forma Therapeutics, Inc.In forceMedium confidence
13 more term ends in 2039 · Pro
10 of 23 patents shown. Soonest term end first, then patent number.
Pro members see all 23.
Upgrade to Pro
18 of these are in force and held by Forma Therapeutics, Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited